Transcriptional repressor NIR interacts with the p53-inhibiting ubiquitin ligase MDM2

Nucleic Acids Research

Volumn 42, Issue 6, 2014, Pages 3565-3579

  Heyne, Kristina ^a   Förster, Juliane ^a   Schüle, Roland ^b   Roemer, Klaus ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LINE, TUMOR; HELA CELLS; HUMANS; PROTO-ONCOGENE PROTEINS C-MDM2; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION;

EID: 84898987794     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt1371     Document Type: Article

References (46)

1. Hublitz, P., Kunowska, N., Mayer, U. P., Muller, J. M., Heyne, K., Yin, N., Fritzsche, C., Poli, C., Miguet, L., Schupp, I. W. et al. (2005) NIR is a novel INHAT repressor that modulates the transcriptional activity of p53. Genes Dev., 19, 2912-2924.
2. Seo, S. B., Macfarlan, T., McNamara, P., Hong, R., Mukai, Y., Heo, S. and Chakravarti, D. (2002) Regulation of histone acetylation and transcription by nuclear protein pp32, a subunit of the INHAT complex. J. Biol. Chem., 277, 14005-14010.
3. Seo, S. B., McNamara, P., Heo, S., Turner, A., Lane, W. S. and Chakravarti, D. (2001) Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell, 104, 119-130.
4. Li, F., Macfarlan, T., Pittman, R. N. and Chakravarti, D. (2002) Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. J. Biol. Chem., 277, 45004-45012.
5. Choi, Y. B., Ko, J. K. and Shin, J. (2004) The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains. J. Biol. Chem., 279, 50930-50941.
6. Kutney, S. N., Hong, R., Macfarlan, T. and Chakravarti, D. (2004) A signaling role of histone-binding proteins and INHAT subunits pp32 and Set/TAF-Ibeta in integrating chromatin hypoacetylation and transcriptional repression. J. Biol. Chem., 279, 30850-30855.
7. Schneider, R., Bannister, A. J., Weise, C. and Kouzarides, T. (2004) Direct binding of INHAT to H3 tails disrupted by modifications. J. Biol. Chem., 279, 23859-23862.
8. Heyne, K., Willnecker, V., Schneider, J., Conrad, M., Raulf, N., Schule, R. and Roemer, K. (2010) NIR, an inhibitor of histone acetyltransferases, regulates transcription factor TAp63 and is controlled by the cell cycle. Nucleic Acids Res., 38, 3159-3171.
9. Vousden, K. H. and Lane, D. P. (2007) p53 in health and disease. Nat. Rev. Mol. Cell Biol., 8, 275-283.
10. Vousden, K. H. and Prives, C. (2009) Blinded by the light: the growing complexity of p53. Cell, 137, 413-431.
11. Iwakuma, T. and Lozano, G. (2003) MDM2, an introduction. Mol. Cancer Res., 1, 993-1000.
12. Meek, D. W. and Knippschild, U. (2003) Posttranslational modification of MDM2. Mol. Cancer Res., 1, 1017-1026.
13. Wade, M., Wang, Y. V. and Wahl, G. M. (2010) The p53 orchestra: MDM2 and Mdmx set the tone. Trends Cell Biol., 20, 299-309.
14. Jones, S. N., Roe, A. E., Donehower, L. A. and Bradley, A. (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature, 378, 206-208.
15. Montes de Oca Luna, R., Wagner, D. S. and Lozano, G. (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature, 378, 203-206.
16. Barak, Y., Gottlieb, E., Juven-Gershon, T. and Oren, M. (1994) Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. Genes Dev., 8, 1739-1749.
17. Haupt, Y., Maya, R., Kazaz, A. and Oren, M. (1997) Mdm2 promotes the rapid degradation of p53. Nature, 387, 296-299.
18. Ohtsubo, C., Shiokawa, D., Kodama, M., Gaiddon, C., Nakagama, H., Jochemsen, A. G., Taya, Y. and Okamoto, K. (2009) Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2. Cancer Sci., 100, 1291-1299.
19. Lin, J., Chen, J., Elenbaas, B. and Levine, A. J. (1994) Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev., 8, 1235-1246.
20. Thut, C. J., Goodrich, J. A. and Tjian, R. (1997) Repression of p53-mediated transcription by MDM2: a dual mechanism. Genes Dev., 11, 1974-1986.
21. Kruse, J. P. and Gu, W. (2009) Modes of p53 regulation. Cell, 137, 609-622.
22. Carter, S. and Vousden, K. H. (2009) Modifications of p53: competing for the lysines. Curr. Opin. Genet. Dev., 19, 18-24.
23. Tang, Y., Zhao, W., Chen, Y., Zhao, Y. and Gu, W. (2008) Acetylation is indispensable for p53 activation. Cell, 133, 612-626.
24. Choong, M. L., Yang, H., Lee, M. A. and Lane, D. P. (2009) Specific activation of the p53 pathway by low dose actinomycin D: a new route to p53 based cyclotherapy. Cell Cycle, 8, 2810-2818.
25. Lohrum, M. A., Ludwig, R. L., Kubbutat, M. H., Hanlon, M. and Vousden, K. H. (2003) Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell, 3, 577-587.
26. Dai, M. S. and Lu, H. (2004) Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J. Biol. Chem., 279, 44475-44482.
27. Zhang, Y. and Lu, H. (2009) Signaling to p53: ribosomal proteins find their way. Cancer Cell, 16, 369-377.
28. Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J. and Pavletich, N. P. (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science, 274, 948-953.
29. Poyurovsky, M. V., Katz, C., Laptenko, O., Beckerman, R., Lokshin, M., Ahn, J., Byeon, I. J., Gabizon, R., Mattia, M., Zupnick, A. et al. (2010) The C terminus of p53 binds the N-terminal domain of MDM2. Nat. Struct. Mol. Biol., 17, 982-989.
30. Cheng, Q. and Chen, J. (2011) The phenotype of MDM2 autodegradation after DNA damage is due to epitope masking by phosphorylation. Cell Cycle, 10, 1162-1166.
31. Buschmann, T., Fuchs, S. Y., Lee, C. G., Pan, Z. Q. and Ronai, Z. (2000) SUMO-1 modification of Mdm2 prevents its selfubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell, 101, 753-762.
32. Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J. and Bar-Sagi, D. (1999) Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol., 1, 20-26.
33. Zhang, Y. and Xiong, Y. (1999) Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell, 3, 579-591.
34. Boisvert, F. M., van Koningsbruggen, S., Navascues, J. and Lamond, A. I. (2007) The multifunctional nucleolus. Nat. Rev. Mol. Cell Biol., 8, 574-585.
35. Gautier, T., Robert-Nicoud, M., Guilly, M. N. and Hernandez-Verdun, D. (1992) Relocation of nucleolar proteins around chromosomes at mitosis. A study by confocal laser scanning microscopy. J. Cell Sci., 102, 729-737.
36. Avantaggiati, M. L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A. S. and Kelly, K. (1997) Recruitment of p300/CBP in p53-dependent signal pathways. Cell, 89, 1175-1184.
37. Gu, W. and Roeder, R. G. (1997) Activation of p53 sequencespecific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90, 595-606.
38. Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H. and Nakatani, Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87, 953-959.
39. Dai, M. S., Shi, D., Jin, Y., Sun, X. X., Zhang, Y., Grossman, S. R. and Lu, H. (2006) Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism. J. Biol. Chem., 281, 24304-24313.
40. Xirodimas, D., Saville, M. K., Edling, C., Lane, D. P. and Lain, S. (2001) Different effects of p14ARF on the levels of ubiquitinated p53 and MDM2 in vivo. Oncogene, 20, 4972-4983.
41. Wade, M., Wang, Y. V. and Wahl, G. M. (2010) The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol., 20, 299-309.
42. Wadgaonkar, R. and Collins, T. (1999) Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression. J. Biol. Chem., 274, 13760-13767.
43. Kobet, E., Zeng, X., Zhu, Y., Keller, D. and Lu, H. (2000) MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins. Proc. Natl Acad. Sci. USA, 97, 12547-12552.
44. Ito, A., Kawaguchi, Y., Lai, C. H., Kovacs, J. J., Higashimoto, Y., Appella, E. and Yao, T. P. (2002) MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J., 21, 6236-6245.
45. Llanos, S., Clark, P. A., Rowe, J. and Peters, G. (2001) Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nat. Cell Biol., 3, 445-452.
46. Rubbi, C. P. and Milner, J. (2003) Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J., 22, 6068-6077.